Pfizer Products Inc.

Groton (CT)

Trademarks

More trademarks (40)
Toviaz

No. 564758 · Class 5

protected until Jul 13, 2027
EPDYAD

No. 560575 · Class 5

protected until May 21, 2027
EPTIBRA

No. 560576 · Class 5

protected until May 21, 2027
EPULZ

No. 560577 · Class 5

protected until May 21, 2027
CONSTREK

No. 557330 · Class 5

protected until Feb 9, 2027
VOZEPTI

No. 556663 · Class 5

protected until Jan 31, 2027
LIFE REWARDS

No. 556566 · Classes 9, 38, 41, 44

protected until Jan 11, 2027
TOLEJI

No. 553367 · Class 5

protected until Oct 13, 2026
VERZECRO

No. 551566 · Class 5

protected until Sep 6, 2026
LIFMIOR

No. 550816 · Class 5

protected until Aug 18, 2026
REAMPLA

No. 547912 · Class 5

protected until May 17, 2026
CHANTIX

No. 548037 · Class 5

protected until May 8, 2026
CONSARIO

No. 547163 · Classes 5, 10

protected until Apr 21, 2026
UPBRIGHT

No. 547165 · Classes 5, 10

protected until Apr 21, 2036
ONPOST

No. 546039 · Class 5

protected until Mar 31, 2036
TOLCENDA

No. 546040 · Class 5

protected until Mar 31, 2036
CYMODIC

No. 543579 · Class 5

protected until Jan 13, 2036
CYMODIQ

No. 543580 · Class 5

protected until Jan 13, 2036
CHAMPIX

No. 537616 · Class 5

protected until Jul 21, 2035
CHAMPIX

No. 536547 · Class 5

protected until Jun 27, 2035
CHAMPIX

No. 536548 · Class 5

protected until Jun 27, 2035
Champix

No. 536549 · Class 5

protected until Jun 27, 2035
champix

No. 535650 · Class 5

protected until May 27, 2035
TORGENA

No. 521979 · Class 5

protected until Mar 24, 2034
DEVRIAZ

No. 519792 · Class 5

protected until Feb 13, 2034
THEROSCA

No. 518780 · Class 5

protected until Dec 4, 2033
TILANX

No. 506075 · Class 5

protected until Aug 13, 2032
TRESCALA

No. 502755 · Class 5

protected until Jul 1, 2032
INLYTA

No. 496383 · Class 5

protected until Jan 29, 2032
SAYANA

No. 496384 · Class 5

protected until Jan 29, 2032
BRAMANT

No. 496390 · Class 5

protected until Jan 29, 2032
DIFLUCAN

No. 356192 · Class 5

protected until Jul 8, 2027
PROFELDEN

No. 354409 · Class 5

protected until Apr 8, 2027
VOIZELLE

No. 643310 · Class 5

deleted Nov 25, 2023
LIFMIOR

No. 608081 · Class 5

deleted Jun 5, 2021
OLTROLA

No. 599415 · Class 5

deleted Oct 23, 2020
SAVGO

No. 579185 · Class 5

deleted May 29, 2019
VMEERA

No. 577233 · Class 5

deleted Feb 12, 2019
ERUZENT

No. 575557 · Class 5

deleted Nov 6, 2018
NRX50

No. 563900 · Class 5

deleted Mar 20, 2018

Holder of 267 trademarks, 43 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property. The register names a holder by name and address only, so a mark is listed here when its holder’s name is this entity’s.

Designs

Holder of one design registration, 0 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property. A design is listed here when its holder’s name is this entity’s.

Patents

More trademarks (40)
MAKROLIDE AUF ERYTHROMYCINBASIS

EP2125851

Deleted
TRIZYKLISCHE VERBINDUNGEN UND DEREN VERWENDUNG ALS GLUCOCORTICOIDREZEPTORMODULATOREN

EP2114888

Deleted
TRIZYKLISCHE VERBINDUNGEN UND DEREN VERWENDUNG ALS GLUCOCORTICOIDREZEPTORMODULATOREN

EP2114970

Deleted
TOSYLATSALZ EINER THERAPEUTISCHEN VERBINDUNG UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAMIT

EP2124933

Deleted
Verfahren zur Herstellung von 3-(4-(2,4-Difluorbenzyloxy)-3-brom-6-methyl- 2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamid

EP2102161

Deleted
SUCCINATSALZ VON 2-((4-(1-METHYL-4(PYRIDIN-4-YL)-1H-PYRAZOL-3-YL)PHENOXY)METHYL)CHINOLIN

EP2125786

Deleted
SPIROKETONE ALS INHIBITOREN VON ACETYL-COA-CARBOXYLASE

EP2097420

Deleted
PYRAZOLINVERBINDUNGEN ALS MINERALOCORTICOIDREZEPTORANTAGONISTEN

EP2089367

Deleted
PYRIDO(2,3-D)PYRIMIDINONVERBINDUNGEN UND IHRE VERWENDUNG ALS PI3-INHIBITOREN

EP2074122

Deleted
PYRIMIDONVERBINDUNGEN ALS GSK-3-INHIBITOREN

EP2057141

Deleted
EP2-AGONIST

EP2059507

Deleted
TARTRATSALZ VON (7S)-7-[(5-FLUOR-2-METHYLBENZYL)OXY]-2-[(2R)-2-METHYLPIPERAZIN-1-YL]-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDIN

EP2044029

Deleted
PENEM-PRODRUGS

EP2044085

Deleted
TESTVERFAHREN FÜR ZIRKULIERENDE TUMORZELLEN

EP2027470

Deleted
ALS ANTIKREBSMITTEL GEEIGNETE TRIAZOLOPYRAZINDERIVATE

EP2018383

Deleted
HETEROBICYCLISCHE AMIDE ZUR PRÄVENTION UND BEHANDLUNG VON DURCH GLUCOKINASE-VERMITTELTEN KRANKHEITEN

EP2010520

Deleted
Kondensierte Heterocyclische Phenylamidoverbindungen zur Prävention und Behandlung von durch Glucokinase vermittelten Krankheiten

EP2463283

Deleted
PYRIDIN[3,4-B]PYRAZINONE

EP2013208

Deleted
DIBENZYLAMINDERIVATE ALS CETP-INHIBITOREN

EP1994015

Deleted
BENZOXAZINON- UND BENZOXAZEPINONOXAZOLIDINONE ALS ANTIBAKTERIELLE MITTEL

EP1987025

Deleted
CARBONYLAMINOPYRROLOPYRAZOLE, WIRKSAME KINASEHEMMER

EP1979356

Deleted
PYRIMIDINDERIVATE ZUR BEHANDLUNG VON ANORMALEM ZELLWACHSTUM

EP1966192

Deleted
ALS PDE5-INHIBITOREN VERWENDETE PYRAZOLO[4,3-D]PYRIMIDIN-5-YLDERIVATE

EP1948661

Deleted
HISTAMIN-3-REZEPTORANTAGONISTEN

EP1951660

Deleted
PYRIDINAMINOSULFONYLSUBSTITUIERTE BENZAMIDE ALS INHIBITOREN VON CYTOCHROM P450 3A4 (CYP3A4)

EP1937639

Deleted
PYRROLO[2,3-D]PYRIMIDINDERIVATE, IHRE ZWISCHENPRODUKTE UND SYNTHESE

EP1913000

Deleted
TRANSDERMALES SYSTEM FÜR VARENICLIN

EP1909773

Deleted
HISTAMIN-3-REZEPTORANTAGONISTEN

EP1899296

Deleted
STEREOSELEKTIVES HYDRIERVERFAHREN ZUR HERSTELLUNG VON CIS-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YL-ETHOXY)-PHENYL]-2-METHOXY-5,6,7,8-TETRAHYDRONAPHTHALIN-HYDROCHLORID

EP1899310

Deleted
BICYCLISCHE [3.1.0]-HETEROARYLAMIDE ALS TYP-I-GLYCINTRANSPORTINHIBITOREN

EP1869019

Deleted
ANTI-CTLA-4-ANTIKÖRPERZUSAMMENSETZUNGEN

EP1865986

Deleted
Antikörperzusammensetzungen gegen CTLA-4

EP2620450

Deleted
SCHNELL ZERFALLENDES MIKROPORÖSES BINDEMITTEL UND HERSTELLUNGSVERFAHREN DAFÜR

EP1845947

Deleted
HETEROAROMATISCHE CHINOLINVERBINDUNGEN UND DEREN VERWENDUNG ALS PDE10-INHIBITOREN

EP1841757

Deleted
MAKROLIDE

EP1836211

Deleted
RNA-BIOTEST

EP1766070

Deleted
ZUR BEHANDLUNG VON KREBS GEEIGNETE PYRROLOPYRIMIDINDERIVATE

EP1773836

Deleted
PROLINDERIVATE UND DEREN VERWENDUNG ALS DIPEPTIDYLPEPTIDASE-IV-INHIBITOREN

EP1753748

Deleted
Prolinderivate und deren Verwendung als Dipeptidylpeptidase-IV-Inhibitoren

EP2116541

Deleted
Formen von Atorvastatinsalzen mit Benethamin

EP2540704

Deleted

Holder of 384 patents, 5 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.